PF

Paul R. Fatheree

TI Theravance Biopharma R&D Ip: 5 patents #2 of 39Top 6%
📍 San Francisco, CA: #276 of 7,035 inventorsTop 4%
🗺 California: #2,940 of 66,859 inventorsTop 5%
Overall (2021): #20,908 of 548,734Top 4%
6
Patents 2021

Issued Patents 2021

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11160810 Fused imidazo-piperidine JAK inhibitor compound Robert Murray McKinnell, Venkat R. Thalladi, Hao Zhang, Lan Jiang, Marta Dabros +1 more 2021-11-02
11110095 Pyrimidine compounds as JAK kinase inhibitors Ryan Hudson, Jennifer Kozak, Melissa Fleury, Anne-Marie Beausoleil, Dante D. Podesto +1 more 2021-09-07
10968222 2-azabicyclo hexane JAK inhibitor compound Lan Jiang 2021-04-06
10954237 JAK inhibitors containing a 4-membered heterocyclic amide Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden 2021-03-23
10913740 JAK kinase inhibitor compounds for treatment of respiratory disease John R. Jacobsen, Gary E. L. Brandt, Noah Benjamin, Marta Dabros, Venkat R. Thalladi 2021-02-09
10889553 Asymmetric triazole benzamide derivatives and the compositions and methods of treatment regarding the same Jennifer Johnston 2021-01-12